VaishaleePadgaonkarKenkreMD

PubMed

• Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T.
  Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T...> ;Blood Advances. 2024 Mar 26
• 1 citations
  Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
  Catherine S Diefenbach, Thomas A Jandl, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Jacob D Soumerai, Deepa Jagadeesh, Adam Asch, Abhij...> ;British Journal of Haematology. 2024 Mar 19
• Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy.
  Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Br...> ;Blood Advances. 2024 Mar 18
• 3 citations
  EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
  Yunxia Liu, Shuichi Kimpara, Nguyet M Hoang, Anusara Daenthanasanmak, Yangguang Li, Li Lu, Vu N Ngo, Paul D Bates, Longzhen Song, Xiaoyue Gao, Samantha Bebel, Madelyn ...> ;Blood. 2023 Nov 30
• Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
  Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacues Azzi, Vaishalee P Kenkre, Che...> ;Blood Advances. 2023 Dec 12
• TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience.
  Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, Joseph K Burkholder, Kreg Grindle, Jan McMannes, KyungMann Kim, Natalie Callander, Mark Juckett, Walter Longo, Peim...> ;Leukemia & Lymphoma. 2023 Aug 10
• 4 citations
  Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
  Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P Kenkre, Sally Arai, Cheryl Ch...> ;American Journal of Hematology. 2023 Mar 1
• 2 citations
  Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
  Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, Nishitha Reddy, Julia Sheets, David M Weiner, Praveen Ramakrishnan Geethakumar...> ;Blood Advances. 2023 Jan 10
• 5 citations
  Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
  Rutherford, S., Yin, J., Pederson, L., Perez Burbano, G., LaPlant, B., Shadman, M., Li, H., LeBlanc, M., Kenkre, V., Hong, F., Blum, K., Dockter, T., Martin, P., Jung,...> ;Journal of Clinical Oncology. 2023 Jan 10
• 10 citations
  Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
  Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
• 14 citations
  Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicen...
  John M Pagel, Jacob D Soumerai, Nishitha Reddy, Deepa Jagadeesh, Anastasios Stathis, Adam Asch, Huda Salman, Vaishalee P Kenkre, Alexia Iasonos, Judith Llorin-Sangalan...> ;The Lancet. Oncology. 2022 Aug 1
• 4 citations
  Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
  Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, Nishitha Reddy, Julia Sheets, David M Weiner, Praveen Ramakrishnan Geethakumar...> ;Journal of Hematology & Oncology. 2022 Jul 16
• 31 citations
  Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
  Joanna Zurko, Jeremy Ramdial, Mazyar Shadman, Sairah Ahmed, Aniko Szabo, Lorenzo Iovino, Ana Alarcon Tomas, Craig Sauter, Miguel-Angel Perales, Nirav N Shah, Utkarsh H...> ;Haematologica. 2023 Jan 1
• 7 citations
  Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
  Loretta J Nastoupil, John Kuruvilla, Julio C Chavez, Fontanet Bijou, Thomas E Witzig, Armando Santoro, Ian W Flinn, Carola Boccomini, Vaishalee P Kenkre, Paolo Corradi...> ;Ejhaem. 2022 May 1
• 29 citations
  NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
  Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, Richard F Ambinder, Philippe Armand, Celeste M Bello, Cecil M Benitez, Weina Chen, Bouthaina Dabaja, Megan E Daly, Leo ...> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 1
• 4 citations
  Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
  Vincent Ribrag, Julio C Chavez, Carola Boccomini, Jason Kaplan, Jason C Chandler, Armando Santoro, Paolo Corradini, Ian W Flinn, Ranjana Advani, Philippe A Cassier, Ra...> ;Ejhaem. 2022 Feb 1
• 5 citations
  Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use t...
  Devon D. Miller, Joseph A. Krenzer, Vaishalee P. Kenkre, William Nicholas Rose> ;Case Reports in Medicine. 2021 Nov 30
• 8 citations
  American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Trans...
  Pashna N. Munshi, Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling, Brad S. Kahl, Mats Jerkeman, Mohamed A. Kharfan-Dabaja, Frederick ...> ;Transplantation and Cellular Therapy. 2021 Sep 1
• 17 citations
  ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
  Pashna N. Munshi, Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling, Brad S. Kahl, Mats Jerkeman, Mohamed A. Kharfan-Dabaja, Frederick ...> ;Bone Marrow Transplantation. 2021 Aug 20
• 5 citations
  Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
  Christopher D'Angelo, Walter Hanel, Yi Chen, Menggang Yu, David T. Yang, Ling Guo, Reem Karmali, Madelyn Burkart, Colleen Ciccosanti, Kevin A. David, Zachary Risch, Ca...> ;Hematological Oncology. 2021 Aug 4
• 17 citations
  HIV-associated Burkitt lymphoma: Outcomes from a US-UK collaborative analysis
  Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim...> ;Blood Advances. 2021 Jul 27
• 26 citations
  Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study.
  Matthew S. Davids, Andrew W. Roberts, Vaishalee P. Kenkre, William G. Wierda, Abhijeet Kumar, Thomas J. Kipps, Michelle Boyer, Ahmed Salem, John Pesko, Jennifer Arzt, ...> ;Clinical Cancer Research. 2021 Jun 3
• 39 citations
  Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
  Michael Scordo, Trent P Wang, Kwang Woo Ahn, Yue Chen, Sairah Ahmed, Farrukh T. Awan, Amer Beitinjaneh, Andy I. Chen, Victor A. Chow, Bhagirathbhai Dholaria, Narendran...> ;JAMA Oncology. 2021 Jul 1
• 12 citations
  Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
  Adam Zayac, Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie, Catherine Wei, Seo-Hyun Kim, Seema Naik, Suchitra Sundaram, Nishitha...> ;Haematologica. 2021 Jul 1
• 25 citations
  Burkitt Lymphoma International Prognostic Index
  Adam J. Olszewski, Lasse Hjort Jakobsen, Graham P. Collins, Kate Cwynarski, Veronika Bachanova, Kristie A. Blum, Kirsten M Boughan, Mark Bower, Alessia Dalla Pria, Ale...> ;Journal of Clinical Oncology. 2021 Jan 27
• Join now to see all

Abstracts/Posters

• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
  Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Vaishalee P. Kenkre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Avadomide (CC-), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018